Viking offers asymmetric upside in GLP-1 drugs with positive trial data, strong cash, and buyout potential despite biotech ...
Despite the physical and financial risks, a 58-year-old Lycoming College freshman is determined to succeed. He balances ...
PetroChina has surged 346% since 2021, supported by strong gas demand, low P/E, and solid fundamentals amid sector headwinds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback